Thomas Bäckström, CEO of BTB Pharma receives founding from Sten K Johnson’s Foundation second year in a row
On 13th of June, 61 happy fellows gathered at Lund University School of Economics to receive scholarships from Sten K Johnsons Foundation. It was the Foundation’s fifth scholarship award.
The award to BTB Pharma will be used to explore new possibilities to help people with Multiple Sclerosis (MS). The title of the project is: “New thinking for the treatment of autoimmune disease Multiple sclerosis: Verification of a vaccine. Part II”
The purpose is to develop a vaccine for the treatment of MS. Treatment of MS in an animal model has been successful. The ambition is to take this vaccine to the market. Today’s medicines against autoimmune diseases are ineffective and not without side effects. Therefore, there is a great need to develop effective and safe treatments.
For further information regarding this award, Sten K Johnsson’s Foundation